ZURICH (Reuters) — Swiss generic drug manufacturer Sandoz has formalized a draft anti-dumping complaint submitted to the European Commission over... Read more
Category: Uncategorized
Pfizer, Innovent Biologics strike $10.5 billion oncology alliance amid China biotech licensing boom
U.S. pharmaceutical flagship Pfizer and Chinese drugmaker Innovent Biologics have entered into a definitive global licensing and collaboration agreement valued... Read more
GSK, Ionis unveil Phase 3 data for hepatitis B candidate positioned as a landmark ‘functional cure’
Pharmaceutical flagships GSK and Ionis Pharmaceuticals have formally published positive primary data from two pivotal Phase III trials evaluating bepirovirsen,... Read more
AstraZeneca’s Imfinzi captures FDA approval for high-risk bladder cancer, marking first advancement in 30 years
The United States Food and Drug Administration (FDA) has granted formal regulatory approval to AstraZeneca’s PD-L1 inhibitor, Imfinzi (durvalumab), for... Read more
Herbalife Vietnam generates over 2,000 billion VND in Q1/2026, widening its revenue gap with China
Global nutrition conglomerate Herbalife Ltd. has formally released its fiscal results for the first quarter of 2026 within its 10-Q... Read more
Vietnam’s Ministry of Health slashes major drug firms with heavy fines, orders nationwide recall of non-compliant cosmetics
The Drug Administration of Vietnam, operating under the Ministry of Health, has issued an extensive series of administrative sanctions against... Read more
Ministry of Health and AstraZeneca Vietnam accelerate strategic partnership for healthcare sustainability
On the morning of May 28, at the headquarters of the Ministry of Health, Assoc. Prof. Dr. Vu Manh Ha,... Read more
Ministry of Health and Johnson & Johnson accelerate strategic partnership in Pharmaceuticals and Medical Technology
On May 28, at the headquarters of the Ministry of Health, Assoc. Prof. Dr. Vu Manh Ha, Alternate Member of... Read more
Sanofi’s venglustat captures US FDA priority review for type 3 Gaucher disease
French biopharmaceutical flagship Sanofi announced that the U.S. Food and Drug Administration (FDA) has formally accepted the New Drug Application... Read more








